This study aims to investigate the recent controversy surrounding the existence of stock-specific momentum. Stock momentum consists of both factor- and stock-specific components, but the risk associated with factor momentum might hinder the impact of stock-specific momentum. Using earnings announcement returns that occur during the formation months of the stock momentum strategy, the study captures a component largely unaffected by factor momentum, thereby mitigating the bad-model problem. This stock-specific momentum source predicts future returns, does not reverse in the long run, and is pervasive, as similar results are found in the US, Europe, and Japan over the last 30 years.
Gérard et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: